Start free

Strata Critical Medical, Inc. (SRTA) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 9, 2026.

Filings shown
26
Open-market buys
1
Open-market sells
4
Buys, 10b5-1 box not checked
1 of 1

Counts cover the 26 most recent Form 4 filings Tradune holds for SRTA (filed May 8 – Nov 9, 2026); the score below covers only the trailing 90 days (1 buy, 0 sells). SEC EDGAR Form 4 filings for SRTA last checked Nov 21, 2026, 09:00 UTC; the latest SRTA filing Tradune holds was filed Nov 9, 2026. This is not guaranteed to be the complete record — see SRTA's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 9 filings Tradune holds for SRTA filed Sep 10 – Nov 9, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Andrew LauckDirector 1 0 2,000 — +$9,998

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score

56/ 100

Net insider purchases
1 distinct buyer1 buy · 0 sell txofficer buying

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at SRTA

Insiders reported 1 open-market purchase of SRTA between May 8, 2026 and Nov 9, 2026, across 1 distinct buyer. The most recent purchase was reported by Andrew Lauck (Director) on Nov 5, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Andrew Lauck Director · filed Nov 9, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 2,000 $5.00 172,902 +1.2% Nov 5, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Scott M. Wunsch CEO, Logistics · filed Oct 30, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 44,996 $4.76 746,254 −5.7% Oct 28, 2026
Grant / award 57,173 — 732,661 +8.5% Oct 28, 2026
Grant / award 57,173 — 789,834 +7.8% Oct 28, 2026
Grant / award 1,416 — 791,250 +0.2% Oct 28, 2026
Grant / award 2,658 — 675,488 +0.4% Jul 30, 2026
Grant / award 9,787 — 672,830 +1.5% Jul 30, 2026
Melissa M. Tomkiel Co-CEO and General Counsel · filed Sep 25, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 90,797 $5.27 2,153,678 −4.0% Sep 24, 2026
Grant / award 177,858 — 2,244,475 +8.6% Sep 24, 2026
William A. Heyburn Co-CEO and CFO · filed Sep 25, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 177,858 — 1,856,206 +11% Sep 24, 2026
Tax withholding 98,356 $5.27 1,757,850 −5.3% Sep 24, 2026
Louis R. Verdetto CEO, Clinical Services · filed Sep 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 5,697 $5.31 1,128,096 −0.5% Sep 8, 2026
Scott M. Wunsch CEO, Logistics · filed Sep 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 5,711 $5.31 663,043 −0.9% Sep 8, 2026
Amir Cohen Chief Accounting Officer · filed Sep 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 4,645 $5.31 177,154 −2.6% Sep 8, 2026
Melissa M. Tomkiel Co-CEO and General Counsel · filed Sep 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 29,730 $5.31 2,066,617 −1.4% Sep 8, 2026
William A. Heyburn Co-CEO and CFO · filed Sep 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 31,671 $5.31 1,678,348 −1.9% Sep 8, 2026
Reginald Love Director · filed Aug 13, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 5,091 $5.75 146,481 −3.4% Aug 10, 2026
Scott M. Wunsch CEO, Logistics · filed Aug 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 13,992 $5.09 668,754 −2.0% Jul 31, 2026
Grant / award 57,172 — 682,746 +9.1% Jul 30, 2026
William A. Heyburn Co-CEO and CFO · filed Aug 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 199,209 $5.09 1,710,019 −10% Jul 31, 2026
Grant / award 179,160 — 1,909,228 +10% Jul 30, 2026
Grant / award 181,071 — 1,730,068 +12% Jul 30, 2026
Melissa M. Tomkiel Co-CEO and General Counsel · filed Aug 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 212,309 $5.09 2,096,347 −9.2% Jul 31, 2026
Grant / award 208,929 — 2,101,703 +11% Jul 30, 2026
Grant / award 206,953 — 2,308,656 +9.8% Jul 30, 2026
Amir Cohen Chief Accounting Officer · filed Aug 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 34,015 $5.09 181,799 −16% Jul 31, 2026
Grant / award 41,786 — 188,394 +29% Jul 30, 2026
Grant / award 27,420 — 215,814 +15% Jul 30, 2026
William L. Cook III Director · filed Aug 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 44,438 — 97,671 +83% Jul 30, 2026
Reginald Love Director · filed Aug 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 37,675 — 151,572 +33% Jul 30, 2026
Edward M. Philip Director · filed Aug 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 30,913 — 265,078 +13% Jul 30, 2026
Robert S. Wiesenthal Director · filed Aug 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 50,234 — 5,325,896 +1.0% Jul 30, 2026
Andrew Lauck Director · filed Aug 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 35,260 — 170,902 +26% Jul 30, 2026
William A. Heyburn amended Co-CEO and CFO · filed Jun 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 31,671 $5.87 1,548,997 −2.0% Jun 8, 2026
Amir Cohen amended Chief Accounting Officer · filed Jun 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 4,655 $5.87 146,608 −3.1% Jun 8, 2026
Melissa M. Tomkiel amended Co-CEO and General Counsel · filed Jun 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 29,730 $5.87 1,892,774 −1.5% Jun 8, 2026
Scott M. Wunsch amended CEO, Logistics · filed Jun 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 5,550 $5.87 625,574 −0.9% Jun 8, 2026
Amir Cohen Chief Accounting Officer · filed May 26, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 40,575 $5.91 151,263 −21% May 22, 2026
Open-market sale 10b5-1 box checked 10,300 $5.79 191,838 −5.1% May 21, 2026
Amir Cohen Chief Accounting Officer · filed May 13, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 14,306 $5.79 202,138 −6.6% May 11, 2026

Listing the 25 most recent of 26 Form 4 filings held for SRTA; the 1 older filing (filed May 8 – May 8, 2026) is counted above but not listed here — see SRTA's full Form 4 filing history on SEC EDGAR.

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to SRTA's (Nov 9, 2026).

Frequently asked about SRTA insider activity

How many insiders bought SRTA stock in these Form 4 filings?

1 distinct insider at Strata Critical Medical, Inc. reported 1 open-market purchase (Form 4 code P) of SRTA shares between May 8, 2026 and Nov 9, 2026, the most recent filed by Andrew Lauck (Director) on Nov 5, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Who filed the most recent Form 4 for SRTA?

The most recent Form 4 on this page was filed by Andrew Lauck (Director) on Nov 9, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market SRTA insider sale shown?

The largest open-market sale among the filings shown was 40,575 SRTA shares at $5.91 (about $239,798) by Amir Cohen (Chief Accounting Officer) on May 22, 2026. Value is shares × the price reported on the Form 4; that Form 4 has the Rule 10b5-1 box checked.

Do the recent SRTA insider purchases have the Form 4 10b5-1 box checked?

No. The one SRTA open-market purchase shown was reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Andrew Lauck (Director) on Nov 5, 2026, 2,000 shares.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for SRTA — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.